Artiklar med krav på offentlig åtkomst - Michael GilbertLäs mer
Inte tillgängliga någonstans: 2
Counterfeit medications and fentanyl
TC Green, M Gilbert
JAMA internal medicine 176 (10), 1555-1557, 2016
Krav: US National Institutes of Health
Monitoring for fentanyl within Australian supervised injecting facilities: Findings from feasibility testing of novel methods and collaborative workshops
S Nielsen, M Barratt, S Hiley, M Bartlett, J Latimer, M Jauncey, C Roux, ...
International Journal of Drug Policy 115, 104015, 2023
Krav: National Health and Medical Research Council, Australia
Tillgängliga någonstans: 4
Opioid overdose prevention programs providing naloxone to laypersons—United States, 2014
E Wheeler, TS Jones, MK Gilbert, PJ Davidson
Morbidity and Mortality Weekly Report 64 (23), 631, 2015
Krav: US National Institutes of Health
Using social listening data to monitor misuse and nonmedical use of bupropion: a content analysis
LS Anderson, HG Bell, M Gilbert, JE Davidson, C Winter, MJ Barratt, ...
JMIR public health and surveillance 3 (1), e6174, 2017
Krav: National Health and Medical Research Council, Australia
Principles and Metrics for Evaluating Oregon’s Innovative Drug Decriminalization Measure
J Netherland, AH Kral, DC Ompad, CS Davis, RN Bluthenthal, ...
Journal of Urban Health 99 (2), 328-331, 2022
Krav: US National Institutes of Health, Arnold Ventures LLC
Utility of gas chromatography infrared spectroscopy (GC-IR) for the differentiation of positional isomers of fentanyl related substances
K Ferguson, SL Tupik, H Haddad, J Perr, M Gilbert, R Newman, J Almirall
Forensic Chemistry 29, 100425, 2022
Krav: US National Science Foundation
Publikations- och finansieringsuppgifter tas fram automatiskt av ett datorprogram.